Our concepts of the pathogenesis of acute coronary syndromes have evolved considerably over time. Our concepts about the acute coronary syndromes have evolved markedly since the founding of the ...

MONCYTE Health, a diagnostics company based in Helsinki, has raised €1 million in a seed funding round to advance its ...

Cardiovascular disease is the primary cause of death worldwide, with high cholesterol being one of most important risk factors of the disease. High blood cholesterol can lead to the formation of ...

2021;18(10):689-700. 5. Cannon CP, et al. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. JAMA Cardiol. 2021;6(9):1 ...

However, more than 70% of patients receiving lipid-lowering therapies do not achieve their LDL- cholesterol target, underscoring the need for new treatment options. AZ said YS2302018 has potential in ...

The increasing use of drugs and alcohol by pregnant women has resulted in a population of children with unique neurodevelopmental behaviors. Of 223 children evaluated in a multidisciplinary child ...

The availability of multiple lipid-lowering drugs and supplements provides new opportunities for patients to achieve target lipid levels. However, the variety of therapeutic options poses a ...

This study aimed to assess the causal relationship between genetically proxied lipid-lowering drugs and skin cancers and psoriasis. Methods: Two-sample Mendelian randomization (MR) analysis was ...

Models were adjusted with age, sex, race, BMI (body mass index), MET (metabolic equivalent task), TDI (Townsend Deprivation Index), smoking and drinking status, diet score, fasting time, family ...